Johnson & Johnson (JNJ)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Johnson & Johnson, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Johnson & Johnson (JNJ) has returned 18.74% so far this year and 51.50% over the past 12 months. Over the last ten years, JNJ has returned 11.41% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Jan 2, 1970, JNJ's average daily return is +0.06%, while the average monthly return is +1.14%. At this rate, your investment would double in approximately 5.1 years.

Historically, 58% of months were positive and 42% were negative. The best month was Feb 1975 with a return of +21.2%, while the worst month was May 1984 at -17.4%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 9 months.

On a daily basis, JNJ closed higher 49% of trading days. The best single day was Oct 13, 2008 with a return of +12.2%, while the worst single day was Oct 19, 1987 at -18.4%.

Johnson & Johnson has an annualized alpha of 7.98%, beta of 0.71, and R² of 0.29 versus S&P 500 Index. Calculated based on daily prices since January 05, 1970.

• This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (86.14%) than losses (63.76%) — typical of diversified or defensive assets.
• R² of 0.29 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

JNJ ranks 94 for risk / return — in the top 94% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Johnson & Johnson (JNJ) and compare them to a chosen benchmark (S&P 500 Index).

Johnson & Johnson provided a 2.13% dividend yield over the last twelve months, with an annual payout of $5.20 per share. The company has been increasing its dividends for 25 consecutive years, earning it the status of a dividend aristocrat.

The table displays the monthly dividend distributions for Johnson & Johnson. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Johnson & Johnson. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Johnson & Johnson was 50.67%, occurring on Apr 25, 1977. Recovery took 1034 trading sessions.

The current Johnson & Johnson drawdown is 1.66%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Johnson & Johnson over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Johnson & Johnson is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.